Activation of soluble guanylate cyclase by nitric oxide is increased in lymphocytes from both rats chronically exposed to 2,5-hexanedione and workers chronically exposed to n-hexane

Toxicology

Volumn 229, Issue 1-2, 2007, Pages 73-78

  Prieto Castello M J ^a   Hernandez Viadel M L ^b   Cardona, A ^a   Marhuenda, D ^a   Felipo, V ^b  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

2,5 Hexanedione; n Hexane; Neurotoxicity; Nitric oxide; Risk assessment; Soluble guanylate cyclase

Indexed keywords

ACETONYLACETONE; DRINKING WATER; GUANYLATE CYCLASE; HEXANE; NITRIC OXIDE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SHOE INDUSTRY; STATISTICAL SIGNIFICANCE; URINALYSIS;

ADHESIVES; ADULT; ANIMALS; CYCLIC GMP; ENVIRONMENTAL MONITORING; ENZYME ACTIVATION; FEMALE; GUANYLATE CYCLASE; HEXANES; HEXANONES; HUMANS; INHALATION EXPOSURE; LYMPHOCYTES; MALE; MIDDLE AGED; NITRIC OXIDE; OCCUPATIONAL EXPOSURE; PENICILLAMINE; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; WATER SUPPLY;

RATTUS NORVEGICUS;

EID: 33845496717     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.10.002     Document Type: Article

References (21)

1. Ahonen I., and Schimberg R.W. 2,5-Hexanedione excretion after occupational exposure to n-hexane. Br. J. Ind. Med. 45 (1988) 133-136
2. Boulton C.L., Southam E., and Garthwaite J. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience 69 (1995) 699-703
3. Cardona A., Marhuenda D., Martí J., Brugnone F., and Perbellini L. Biological monitoring of occupational exposure to n-hexane by measurement of urinary 2,5-hexanedione. Int. Arch. Occup. Environ. Health 65 (1993) 71-74
4. Cardona A., Marhuenda D., Prieto M.J., Martí J., Periago J.F., and Sanchez J.M. Behaviour of urinary 2,5-hexanedione in occupational co-exposure to n-hexane and acetone. Int. Arch. Occup. Environ. Health 68 (1996) 88-93
5. Governa M., Calisti R., Coppa G., and Tagliavento G. Urinary excretion of 2,5-hexanedione and peripheral polyneuropathies in workers exposed to n-hexane. J. Toxicol. Environ. Health 20 (1987) 128-219
6. Graham D.G. Neurotoxicants and the cytoskeleton. Curr. Opin. Neurol. 12 6 (1999) 733-737
7. Hawkins R.D. NO honey, I don't remember. Neuro 16 (1996) 465-467
8. Hernández-Viadel M., Montoliu C., Monfort P., Canales J.J., Erceg S., Rowan M., Ceccatelli S., and Felipo V. Chronic exposure to 2,5-hexanedione impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in rat brain in vivo. Neurochem. Int. 42 (2003) 525-533
9. Herskowitz A., Ishii N., and Schaumburg H. n-Hexane neuropathy: a syndrome occurring as a result of industrial exposure. N. Engl. J. Med. 285 (1971) 82
10. Humbet P., Niroomand F., Fischer G., Mayer B., KOesling D., Hinsch K., Schultz G., and Bohme E. Preparation of soluble guanylyl cyclase from bovine lung by immunoaffinity chromatography. Meth. Enzymol. 195 (1991) 384-391
11. Iwata M., Takeuchi Y., Hisanaga N., and Ono Y. A study on biological monitoring of n-hexane exposure. Int. Arch. Occup. Environ. Health 51 (1983) 253-260
12. Mutti A., Falzoi S., Lucertini S., Arfini G., Zignani M., Lombardi S., and Franchini I. n-Hexane metabolism in occupationally exposed workers. Br. J. Ind. Med. 41 (1984) 533-538
13. NIOSH. Manual of Analytical Methods (1978), NIOSH, Cincinnati, OH
14. Pastore C., Marhuenda D., Martí J., and Cardona A. Early diagnosis of n-hexane-caused neuropathy. Muscle & Nerve 17 (1994) 981-986
15. Perbellini L., Brugnone F., and Faggionato G. Urinary excretion of the metabolites of n-hexane and its isomers during occupational exposure. Br. J. Ind. Med. 38 (1981) 20-26
16. Perbellini L., Brugnone F., and Pavan I. Identification of the metabolites of n-hexane, cyclohexane, and their isomers in men's urine. Toxicol. Appl. Pharmacol. 53 (1980) 220-229
17. Perbellini L., Marhuenda D., Cardona A., Giuliari C., and Brugnone F. An improved method of analysing 2,5-hexanedione in urine. Br. J. Ind. Med. 47 (1990) 421-424
18. Prieto M.J., Marhuenda D., Roel J., and Cardona A. Free and total 2,5-hexanedione in biological monitoring of workers exposed to n-hexane in the shoe industry. Toxicol. Lett. 145 (2003) 249-260
19. Spencer P.S., and Schaumburg H.H. Experimental neuropathy produced by 2,5-hexanedione a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone. J. Neurol. Neurosurg. Psychiatry 8 (1975) 771-775
20. Stone J.R., and Marletta M. Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide. Biochemistry 35 (1996) 1093-1099
21. Yamada S. An occurrence of polyneuritis by n-hexane in the polyethylene laminating plants. Jpn. J. Ind. Health 6 (1964) 192